TNMG
TNL Mediagene
$0.7800
+30.00%
$1.8M
No data for this timeframe.
Vol
Market Cap$1.8M
Cap SizeNano Cap
SEC Reports2
Recent Activity
Mar 16, 2026
SEC
TNL Mediagene's F-1 registration statement has become effective, allowing the company to proceed with its planned initia
EFFECT — Impact 5/10
Mar 3, 2026
SEC
TNL Mediagene, a Cayman Islands-based media company operating in Japan and Taiwan, is registering the resale of up to 1,
F-1 — Impact 7/10
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$14.00 (Jan 2026)
Current $0.7800
Low $14.00
Median $14.00
High $14.00
1 analysts
$14.00
$14.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 15, 2026 | Benchmark | MAINTAIN | Speculative Buy → Speculative Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $-3.92 ▼ -40.0% | $-3.92 — $-3.92 | 85% YoY | 1 |
Latest Reports
NEUTRAL
EFFECT
5/10
TNL Mediagene's F-1 registration statement has become effective, allowing the company to proceed with its planned initia
Mar 16, 2026
BEARISH
F-1
7/10
TNL Mediagene, a Cayman Islands-based media company operating in Japan and Taiwan, is registering the resale of up to 1,
Mar 3, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jan 2026): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$14.00 mean target (Jan 2026)
$14.00 Low
$14.00 High
| Metric | Value |
|---|---|
| Current Price | $0.7800 |
| Target Low | $14.00 |
| Target Mean | $14.00 |
| Target Median | $14.00 |
| Target High | $14.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$-3.92 | $-3.92 | $-3.92 | 84.9% | -40.0% | — | $0.1B | 12.3% | 1 |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 7.7% | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 15, 2026 | Benchmark | MAINTAIN | Speculative Buy | Speculative Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.